Reports for MYLAN PHARMACEUTICALS ULC
Formerly known as UPJOHN CANADA ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Shortage reports
Actual shortage:
20 (3%)
Anticipated shortage:
6 (1%)
Avoided shortage:
88 (12%)
Resolved:
604 (84%)
718
Discontinuation Reports
To be discontinued:
0 (0%)
Discontinued:
235 (100%)
Reversed:
0 (0%)
235
89 (9%)
19 (73%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2023-06-21 | 2023-08-16 | 196061 |
| MYLAN-HYDROXYUREA | 500MG | CAPSULE | Avoided shortage | 2020-10-14 | 2020-10-20 | 126325 |
| MYLAN-HYDROXYUREA | 500MG | CAPSULE | Anticipated shortage | 2025-03-04 | 2025-04-28 | 251917 |
| MYLAN-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2024-09-24 | 2024-12-16 | 238425 |
| MYLAN-HYDROXYUREA | 500MG | CAPSULE | Avoided shortage | 2025-01-28 | 2025-03-04 | 248755 |
| MYLAN-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2023-08-16 | 2023-11-06 | 201965 |
| MYLAN-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2020-07-08 | 2020-10-14 | 119721 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Avoided shortage | 2019-05-14 | 2019-05-28 | 84073 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2021-11-17 | 2021-12-21 | 149495 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2024-06-11 | 2024-07-09 | 230100 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2017-03-10 | 2019-01-18 | 189 |
| MYLAN-INDAPAMIDE | 2.5MG | TABLET | Resolved | 2022-02-23 | 2022-03-10 | 155442 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2022-01-18 | 2022-01-26 | 152983 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Avoided shortage | 2022-02-02 | 2022-02-25 | 154043 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2017-03-10 | 2017-03-15 | 191 |
| MYLAN-INDAPAMIDE | 2.5mg | Tablet | Resolved | 2017-03-10 | 2017-03-31 | 194 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2020-04-02 | 2020-06-17 | 110480 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2019-05-28 | 2019-08-14 | 84997 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2022-09-01 | 2022-09-07 | 168381 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2024-11-18 | 2025-01-07 | 243383 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53608 |
| MYLAN-BUPRENORPHINE/NALOXONE | 8MG 2MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94048 |
| MYLAN-BUPRENORPHINE/NALOXONE | Discontinued | 2019-09-17 | 2019-09-18 | 94044 | ||
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
| MYLAN-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53628 |
| MYLAN-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53621 |
| MYLAN-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-07-03 | 2018-08-11 | 53616 |
| MYLAN-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53611 |
| MYLAN-CARVEDILOL | 6.25MG | TABLET | Discontinued | 2017-07-18 | 2018-02-15 | 16108 |
| MYLAN-CARVEDILOL | 25MG | TABLET | Discontinued | 2017-07-17 | 2018-02-15 | 15824 |
| MYLAN-CARVEDILOL | 3.125MG | TABLET | Discontinued | 2017-07-18 | 2018-02-15 | 16105 |
| MYLAN-CARVEDILOL | 12.5MG | TABLET | Discontinued | 2017-07-18 | 2018-02-15 | 16111 |
| MYLAN-CELECOXIB | 100MG | CAPSULE | Discontinued | 2017-11-23 | 2018-07-04 | 30337 |
| MYLAN-CELECOXIB | 200MG | CAPSULE | Discontinued | 2018-04-03 | 2018-08-01 | 44830 |
| MYLAN-CIMETIDINE | 600MG | TABLET | Discontinued | 2017-07-18 | 2017-09-08 | 16096 |
| MYLAN-CIMETIDINE | 300MG | TABLET | Discontinued | 2017-07-18 | 2017-09-08 | 16203 |
| MYLAN-CIMETIDINE | 400MG | TABLET | Discontinued | 2017-07-18 | 2017-09-08 | 16206 |
| MYLAN-CIMETIDINE | 800MG | TABLET | Discontinued | 2017-07-18 | 2017-09-08 | 16211 |
| MYLAN-CIPROFLOXACIN | 750MG | TABLET | Discontinued | 2017-08-24 | 2017-12-02 | 20278 |